[1] Lesmana CRA, Raharjo M, Gani RA. Managing liver cirrhotic complications: overview of esophageal and gastric varices. Clin Mol Hepatol, 2020, 26(4):444-460. [2] 薛晋峰.经颈静脉肝内门体分流术联合胃冠状静脉栓塞术治疗肝硬化门静脉高压症上消化道出血效果观察.中国药物与临床,2020,20(16):2779-2780. [3] Rajesh S, George T, Philips CA, et al. Transjugular intrahepatic portosystemic shunt in cirrhosis: an exhaustive critical update. World J Gastroenterol, 2020, 26(37):5561-5596. [4] Will V, Rodrigues SG, Stirnimann G, et al. Transjugular intrahepatic portosystemic shunt and alfapump system for refractory ascites in liver cirrhosis: outcomes and complications. United European Gastroenterol J, 2020, 8(8):961-969. [5] Schindler P, Heinzow H, Trebicka J, et al. Shunt-induced hepatic encephalopathy in TIPS: current approaches and clinical challenges. J Clin Med, 2020, 9(11):3784. [6] Tong H, Gan C, Wei B, et al. Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis. J Dig Dis, 2021, 22(1): 31-40. [7] 中华医学会肝病学分会.肝硬化肝性脑病诊疗指南.临床肝胆病杂志, 2018, 34(10): 2076-2089. [8] Butterworth RF, McPhail MJW. L-ornithine L-aspartate (LOLA) for hepatic encephalopathy in cirrhosis: results of randomized controlled trials and meta-analyses. Drugs, 2019, 79(S1):31-37. [9] 中华外科学分会门静脉高压症学组.肝硬化门静脉高压症食管胃底静脉曲张破裂出血的诊治共识(2015版).中华普通外科杂志, 2016, 31(2):167-170. [10] Mohkam K, Rode A, Darnis B, et al. Hepatic venous pressure gradient after portal vein embolization: An accurate predictor of future liver remnant hypertrophy. Surgery, 2018, 164(2):227-232. [11] 邓道庭, 柳俊喜, 张红. 肝硬化门静脉高压伴上消化道出血患者胃冠状静脉栓塞联合TIPs术后感染相关因素分析. 中国中西医结合消化杂志, 2020, 28(3):11-14. [12] 杨慧玲,蔺淑梅,张曦,等. 颈静脉肝内门腔静脉分流术联合胃左静脉栓塞术对肝硬化食管胃底静脉曲张破裂出血患者再出血率和预后的影响. 现代消化及介入诊疗,2019, 24(7): 722-726. [13] 中国医师协会介入医师分会. 中国门静脉高压经颈静脉肝内门体分流术临床实践指南(2019版).中华医学杂志, 2019, 99(45):3534-3546. [14] 高旭东,杨昆,张克明,等.经颈静脉肝内门体静脉分流术后肝性脑病发病率的多因素分析.中国综合临床, 2019, 35(6):498-502. [15] 姚运海,罗艳,朱京乐,等.急性食管胃底静脉曲张破裂出血行急诊经颈静脉肝内门体分流术后发生肝性脑病的危险因素分析.临床肝胆病杂志, 2020, 36(2):343-347. [16] 张浩,潘佳佳,蒋晓芬,等.门静脉压力梯度预测TIPS术后高危人群肝性脑病的研究.中华肝脏病杂志,2021,29(1):72-74. [17] 马佳丽,陈旭,何玲玲,等. Child-Pugh评分、MELD评分、MELD-Na评分、APASAL评分和R评分对肝硬化伴食管胃静脉曲张再出血及死亡的预测价值. 临床肝胆病杂志,2020, 36(6): 1278-1283. [18] Moraes ACO, Fonseca-Neto OCLD. The use of meld score (Model For End-Stage Liver Disease) and derivatives in cardiac transplantation. Arq Bras Cir Dig, 2018, 31(2):e1370. [19] Egbe AC, Miranda WR, Veldtman GR, et al. Hepatic venous pressure gradient in fontan physiology has limited diagnostic and prognostic significance. CJC Open, 2020, 2(5): 360-364. [20] Zhou Y, Zhang W, Zhang Z, et al. PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks. Eur J Gastroenterol Hepatol, 2020, 32(9):1235-1243. |